J.P. Morgan Private Wealth Advisors’s Matinas BioPharma MTNB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-634
| Closed | -$26K | – | 1991 |
|
|
2022
Q1 | $26K | Hold |
634
| – | – | ﹤0.01% | 1971 |
|
|
2021
Q4 | $32K | Hold |
634
| – | – | ﹤0.01% | 1961 |
|
|
2021
Q3 | $41K | Buy |
+634
| New | +$41K | ﹤0.01% | 1916 |
|
|
2019
Q3 | – | Sell |
-600
| Closed | -$26K | – | 1461 |
|
|
2019
Q2 | $26K | Hold |
600
| – | – | ﹤0.01% | 1363 |
|
|
2019
Q1 | $33K | Hold |
600
| – | – | ﹤0.01% | 1443 |
|
|
2018
Q4 | $18K | Hold |
600
| – | – | ﹤0.01% | 1439 |
|
|
2018
Q3 | $28K | Hold |
600
| – | – | ﹤0.01% | 1554 |
|
|
2018
Q2 | $13K | Hold |
600
| – | – | ﹤0.01% | 1455 |
|
|
2018
Q1 | $23K | Buy |
+600
| New | +$23K | ﹤0.01% | 1269 |
|
|
2017
Q4 | – | Sell |
-600
| Closed | -$40K | – | 1309 |
|
|
2017
Q3 | $40K | Buy |
+600
| New | +$40K | ﹤0.01% | 1221 |
|